Olfr522, a G protein-coupled receptor, holds a pivotal role in the intricate landscape of olfactory signal transduction, orchestrating the detection and interpretation of specific odorants within the olfactory system. This receptor, situated on the membrane of olfactory sensory neurons, serves as a molecular gateway that translates chemical stimuli into intracellular signals, ultimately culminating in the perception of odors. The functional significance of Olfr522 lies in its ability to initiate a cascade of events upon binding to specific odor molecules, triggering a series of intracellular responses that lead to the generation of neuronal signals. This receptor, like others in its family, is an essential component of the olfactory system, contributing to the remarkable sensitivity and specificity exhibited by the sense of smell.
The inhibition of Olfr522 encompasses a diverse array of mechanisms, reflecting the intricate web of signaling pathways and cellular processes involved in olfactory signal transduction. Direct inhibitors exert their influence by interacting with the receptor itself, either through competitive binding or modulation of its conformation, thereby impeding the normal activation process. This includes compounds that alter ion channel dynamics, like Tetrodotoxin, or disrupt neurotransmission through ionotropic glutamate receptors, as exemplified by CNQX. On the other hand, indirect inhibitors operate through targeting key signaling pathways associated with Olfr522 activation. These compounds, such as U0126 and Wortmannin, intervene in intracellular cascades, such as the MAPK and PI3K pathways, respectively, affecting downstream components and altering the overall response of olfactory sensory neurons. The modulation of cAMP levels, achieved by compounds like Forskolin or H-89, further showcases the intricate interplay of molecular events in the inhibition of Olfr522. Understanding these mechanisms provides a nuanced perspective on the potential strategies for selectively modulating olfactory responses, contributing to the exploration of sensory biology and cellular signaling in olfaction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Menthol | 2216-51-5 | sc-202705 sc-202705A | 1 g 50 g | $20.00 $41.00 | 2 | |
Inhibits Olfr522 activation by directly binding to the receptor, disrupting the olfactory signal transduction. Alters ion channel dynamics, hindering normal olfactory neuron response. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Targets the MAPK pathway to indirectly inhibit Olfr522. Blocks MEK phosphorylation, disrupting downstream signaling and suppressing olfactory signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Indirectly inhibits Olfr522 by targeting the PI3K pathway. Modifies intracellular signaling, impacting olfactory receptor neuron function and hindering the activation of Olfr522. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Indirectly inhibits Olfr522 by targeting the ERK pathway. Alters the phosphorylation status of downstream targets, resulting in the inhibition of olfactory signal transduction. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Indirectly inhibits Olfr522 by chelating intracellular calcium, modulating olfactory receptor neuron responses. Alters the olfactory signal transduction process, leading to the suppression of Olfr522 activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Modulates Olfr522 indirectly by inhibiting phosphodiesterase 4 (PDE4), elevating cAMP levels. Alters olfactory signal transduction dynamics and inhibits the activation of Olfr522. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $208.00 | 2 | |
Acts as a direct inhibitor by blocking ionotropic glutamate receptors, affecting neurotransmission. Disrupts olfactory signal transduction, inhibiting Olfr522 activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Targets the p38 MAPK pathway to indirectly inhibit Olfr522. Blocks phosphorylation cascades, disrupting downstream signaling and suppressing olfactory signal transduction. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Acts as a direct inhibitor by blocking epithelial sodium channels (ENaC), impacting ion transport in olfactory receptor neurons. Disrupts the normal olfactory signal transduction process, inhibiting the activation of Olfr522. | ||||||